StockData
PAVmed Inc. logo

PAVmed Inc. (PAVM) stock

PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.51−0.24 (-13.71%)

Close on Nov 17, 2026Market cap $12.07MP/E –Yield –

PAVmed operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

PAVmed's operating cash flow for the twelve months ending Jun 30, 2026 was -$7.73M. For fiscal 2025 it was -$5.21M. The highest annual figure on record is -$1.25M in fiscal 2015.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$5.21M–
FY2024Dec 31, 2024-$33.55M–
FY2023Dec 31, 2023-$52.04M–
FY2022Dec 31, 2022-$70.99M–
FY2021Dec 31, 2021-$40.59M–
FY2020Dec 31, 2020-$21.91M–
FY2019Dec 31, 2019-$13.36M–
FY2018Dec 31, 2018-$8.79M–
FY2017Dec 31, 2017-$6.61M–
FY2016Dec 31, 2016-$4.45M–
FY2015Dec 31, 2015-$1.25M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.66M–
Q1 FY2026Mar 31, 2026-$2.62M–
Q4 FY2025Dec 31, 2025-$1.55M-1750.0%
Q3 FY2025Sep 30, 2025-$896.00K–
Q2 FY2025Jun 30, 2025-$1.18M–
Q1 FY2025Mar 31, 2025-$1.58M–
Q4 FY2024Dec 31, 2024$94.00K–
Q3 FY2024Sep 30, 2024-$8.88M–
Q2 FY2024Jun 30, 2024-$11.66M–
Q1 FY2024Mar 31, 2024-$13.11M–
Q4 FY2023Dec 31, 2023-$11.87M–
Q3 FY2023Sep 30, 2023-$11.09M–
Q2 FY2023Jun 30, 2023-$12.71M–
Q1 FY2023Mar 31, 2023-$16.36M–
Q4 FY2022Dec 31, 2022-$16.82M–
Q3 FY2022Sep 30, 2022-$19.34M–
Q2 FY2022Jun 30, 2022-$22.56M–
Q1 FY2022Mar 31, 2022-$12.26M–
Q4 FY2021Dec 31, 2021-$16.78M–
Q3 FY2021Sep 30, 2021-$8.02M–
Q2 FY2021Jun 30, 2021-$6.63M–
Q1 FY2021Mar 31, 2021-$9.17M–
Q4 FY2020Dec 31, 2020-$6.73M–
Q3 FY2020Sep 30, 2020-$5.84M–
Q2 FY2020Jun 30, 2020-$5.56M–
Q1 FY2020Mar 31, 2020-$3.79M–
Q4 FY2019Dec 31, 2019-$4.09M–
Q3 FY2019Sep 30, 2019-$2.88M–
Q2 FY2019Jun 30, 2019-$2.52M–
Q1 FY2019Mar 31, 2019-$3.87M–
Q4 FY2018Dec 31, 2018-$3.02M–
Q3 FY2018Sep 30, 2018-$1.87M–
Q2 FY2018Jun 30, 2018-$1.70M–
Q1 FY2018Mar 31, 2018-$2.20M–
Q4 FY2017Dec 31, 2017-$1.59M–
Q3 FY2017Sep 30, 2017-$2.37M–
Q2 FY2017Jun 30, 2017-$823.60K–
Q1 FY2017Mar 31, 2017-$1.83M–
Q4 FY2016Dec 31, 2016-$1.20M–
Q3 FY2016Sep 30, 2016-$1.23M–

More PAVmed figures

See a number that looks wrong?